Skip to main content

ADVERTISEMENT

Dimytri Siqueira, MD, PhD

Original Contribution
02/28/2017
This prospective, placebo-controlled trial was conducted in diabetic patients randomized (1:1) to receive either standard DAPT vs TAPT with cilostazol for a minimum of 12 months after PCI with Endeavor zotarolimus-eluting stent.
This prospective, placebo-controlled trial was conducted in diabetic patients randomized (1:1) to receive either standard DAPT vs TAPT with cilostazol for a minimum of 12 months after PCI with Endeavor zotarolimus-eluting stent.
This prospective,...
02/28/2017
Journal of Invasive Cardiology
Original Contribution
05/31/2017
The present study examined the association between Multicenter CTO Registry in Japan (J-CTO) score in predicting failure of percutaneous coronary intervention correlating with the estimated duration of chronic total occlusion.
The present study examined the association between Multicenter CTO Registry in Japan (J-CTO) score in predicting failure of percutaneous coronary intervention correlating with the estimated duration of chronic total occlusion.
The present study examined the...
05/31/2017
Journal of Invasive Cardiology
Original Contribution
03/01/2023
This database analysis of a single-center, high-volume tertiary institution examines preprocedural risk factors of mitral valve restenosis in patients submitted to percutaneous mitral balloon commissurotomy for mitral stenosis.
This database analysis of a single-center, high-volume tertiary institution examines preprocedural risk factors of mitral valve restenosis in patients submitted to percutaneous mitral balloon commissurotomy for mitral stenosis.
This database analysis of a...
03/01/2023
Journal of Invasive Cardiology